4//SEC Filing
Doyle Mittie 4
Accession 0001578563-24-000331
CIK 0001534120other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:23 PM ET
Size
5.7 KB
Accession
0001578563-24-000331
Insider Transaction Report
Form 4
Doyle Mittie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-07-15+234,000→ 234,000 totalExercise: $12.65Exp: 2034-07-15→ Common Stock (234,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the Option Shares vest on July 15, 2025 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001918845
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:23 PM ET
- Size
- 5.7 KB